filmov
tv
Brain tumor vaccine study giving hope to those with deadly glioblastoma

Показать описание
An experimental vaccine is bringing hope to those battling fatal brain tumors.
Early results show the shot doubled survival time for people with glioblastoma, a brain cancer that is usually fatal 16 months from diagnosis.
In July 2017, 10 weeks after her wedding, Katy Sanchez of Chelsea, Michigan, received a devastating diagnosis. She had a glioblastoma brain tumor, and within days had surgery to remove as much as possible. That was followed by radiation and finally chemotherapy, all of which are standard treatment.
Her father scoured the computer looking for guidance, and found a clinical trial of a brain tumor vaccine being done at Cleveland Clinic.
"You know, using an odd turn of phrase, it was kind of a 'no brainer," Katy said of not hesitating to sign up for the trial. "In the face of only having 12 or 15 months to live, you'll pretty much do anything."
Three months after her diagnosis, Sanchez went to the Clinic to start the vaccine therapy. Every 10 weeks, she returns to continue getting the shots, even now six years later. During each of those visits, she also receives an MRI to see if her tumor has returned.
Early results show the shot doubled survival time for people with glioblastoma, a brain cancer that is usually fatal 16 months from diagnosis.
In July 2017, 10 weeks after her wedding, Katy Sanchez of Chelsea, Michigan, received a devastating diagnosis. She had a glioblastoma brain tumor, and within days had surgery to remove as much as possible. That was followed by radiation and finally chemotherapy, all of which are standard treatment.
Her father scoured the computer looking for guidance, and found a clinical trial of a brain tumor vaccine being done at Cleveland Clinic.
"You know, using an odd turn of phrase, it was kind of a 'no brainer," Katy said of not hesitating to sign up for the trial. "In the face of only having 12 or 15 months to live, you'll pretty much do anything."
Three months after her diagnosis, Sanchez went to the Clinic to start the vaccine therapy. Every 10 weeks, she returns to continue getting the shots, even now six years later. During each of those visits, she also receives an MRI to see if her tumor has returned.
Brain tumor vaccine study giving hope to those with deadly glioblastoma
Dad Of 6-Year-Old With Brain Cancer Gives Update On Vaccine Trial
Brain cancer vaccine being tested on Roswell Park patients
Autologous Tumor Lysate-Loaded Dentritic Cell Vaccination for Glioblastoma (DCVax)
Study shows progress in vaccine development for deadly brain tumor
Immunotherapy for Brain Cancer, with David Reardon
RPCI Researchers Test Brain Cancer Vaccine in Phase I Trial
'Seeking New Understanding: Novel Approaches to Brain Tumor Therapy'
Duane Mitchell- The Cancer Immunotherapy Revolution and Relevance for Brain Tumors
Duane Mitchell - Advancing Immunotherapy for Malignant Brain Tumors
Ride for Roswell: Brain cancer vaccine SurVaxM gaining worldwide attention
Brainiacs: Breakthrough Treatments: Brain Tumor Vaccines and Direct-to-the-Brain Chemotherapy
New results show vaccine could help fight brain cancer
Vaccine trial at Norton Healthcare underway aimed at treating deadliest form of brain cancer
SurVaxM Phase 2B Trial Now Open at Roswell Park
Gary Kohanbash Discusses Brain Tumor Immunotherapy on Fridays with Friedlander
New study finds rare side effects from COVID-19 vaccine 💉 #Health #Vaccines #COVID19
Michael Platten: Breaking the Wall of Brain Tumor Vaccines | Science Summit 2024
Immunotherapy for Brain Tumors
New Covid vaccine study links jab to heart and brain conditions | WION World DNA
Immunotherapy For Brain Tumors
Clinical Trials for Brain Tumors
Immunotherapy for Brain Tumors
Update in Surgically Based Clinical Trials for Glioma - Manish K. Aghi, MD, PhD
Комментарии